Several rarer epilepsies featuring febrile seizures are caused by mutations in SCN1A, which encodes a brain-expressed sodium channel subunit targeted by many anti-epileptic drugs. The gene discussed is SCN1A; the disease is Febrile seizure (within the age range of 3 months to 6 years).